Страна: Армения
Язык: английский
Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
clindamycin (clindamycin hydrochloride)
Fareva Amboise
J01FF01
clindamycin (clindamycin hydrochloride)
150mg
capsules
(16/2x8/) in blister
Prescription
Registered
2018-12-14
1 1. NAME(S) OF THE MEDICINAL PRODUCT Dalacin 150 mg hard capsules Dalacin 300 mg hard capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Dalacin 150 mg hard capsules: Each capsule contains 150 mg clindamycin (equivalent to 177.515 mg of clindamycin hydrochloride). Dalacin 300 mg hard capsules: Each capsule contains 300 mg clindamycin (equivalent to 355.03 mg of clindamycin hydrochloride). Excipients with known effect _Dalacin 150 mg hard capsule _ Each capsule contains 209.485 mg lactose-monohydrate. _Dalacin 300 mg hard capsule _ Each capsule contains 253.97 mg lactose-monohydrate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM _Dalacin 150 mg hard capsules _ Approximately 440 mg of white powder is filled in each capsule, which is made from hard gelatine that consists of a white upper and lower half designated with black “CLIN 150” and “Pfizer” signs. _ _ _Dalacin 300 mg hard capsules _ Approximately 650 mg of white powder is filled in each capsule, which is made from hard gelatine that consists of a white upper and lower half designated with black “CLIN 300” and “Pfizer” signs. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of infections caused by susceptible _anaerobic_ bacteria or susceptible strains of _Gram positive aerobic_ bacteria, for example, streptococci, staphylococci and pneumococci; and susceptible strains of _Chlamydia _ _trachomatis_. Treatment of patients with penicillin sensitive infections, who are allergic to penicillin. 1. Upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media/chronic suppurative otitis media and scarlet fever. 2. Lower respiratory infections including bronchitis, pneumonia, empyema and lung abscess. 3. Skin and soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, and wound infections. For specific skin and soft tissue infections like erysipelas and paronychia (panaritium), it would seem logical that these conditions would respond very well to clindamyc Прочитать полный документ